2018 Monif group. L-R: Ms Katrina Kan, Mr William O'Brien, Dr Mastura
Monif, Dr Robb Wesselingh, Ms Veronica Woo, Dr James Broadley. Dr Monif is one of the research leaders in the new Department of Neuroscience, specializing in neurology, neuroinflammation and neurological diseases. See more about her group at www.monash.edu/medicine/ccs/neuroscience/research/monif-group. See more about the department's research at www.monash.edu/medicine/ccs/neuroscience/research |
27 Apr 2018
Photo of the week: Dr Mastura Monif's research group
What's on at CCS 30 April-04 May 2018
Professor Nicola Harris, new in the Department of Immunology and Pathology, is presenting on Weds 2 May |
Central Clinical School (CCS) has regular seminar series and postgraduate presentations. Event notices are posted on the CCS Events calendar.
See CCS seminar index: https://www.monash.edu/medicine/ccs/headlines/events-calendar
What's on at CCS 30 April-04 May 2018
Mon | 30/04/2018 | ► | 10:00 | PhD Mid-Candidature seminar: Ms Wing Yu Man |
► | 12:00 | Neuroscience Seminar Series | ||
Tue | 01/05/2018 | ► | 10:00 | MNHS Milestone Chair & Panel forum |
Wed | 02/05/2018 | ► | 11:30 | Seminar: Nicola Harris |
Thur | 03/05/2018 | ► | 09:30 | MPhil Confirmation Milestone: Justin Cole |
► | 11:30 | Cutting Edge Journal Club: Amy Wilson | ||
► | 12:00 | Alfred Grand Rounds |
Recent CCS publications: 21 – 27 April 2018
Dr Vilija Jokubaitis, seen here in a preview shot of CCS's Red Lab Coat Day video which will be released on 1 May to promote awareness of multiple sclerosis research. Vilija is a co-author on a recently published paper on how genetic profiles influence response to treatment. |
Monash study reveals insights into brain injury, blood carbon dioxide levels and hospital deaths
Professor Ravi Tiruvoipati |
A large multi-centre study has made an important finding about the relationship between hypercapnia (high carbon dioxide or CO2) in the blood of patients with acute brain injury and hospital mortality. CO2 makes your blood more acidic which, if not adjusted, can affect your outcomes for the worse.
Professor Ravindranath Tiruvoipati, Adjunct Clinical Professor at the Peninsula Clinical School, Monash University and Intensive Care Specialist at Frankston Hospital, Peninsula Health, was first author on the paper, published in JAMA Neurology.
Participants sought: Can fibromyalgia be reduced by brain stimulation?
The Monash Alfred Psychiatry Research Centre (MAPrc) at the Alfred
Hospital is currently seeking volunteers for a clinical trial of a
non-medication investigational treatment for fibromyalgia (muscle pain).
Theta Burst Stimulation (TBS) is a painless, safe, and non-invasive means of stimulating nerve cells in the brain. We are conducting this study to see whether we can reduce the symptoms of fibromyalgia.
Theta Burst Stimulation (TBS) is a painless, safe, and non-invasive means of stimulating nerve cells in the brain. We are conducting this study to see whether we can reduce the symptoms of fibromyalgia.
Subscribe to:
Posts (Atom)